News mentioning $RARE
831 stories
Aug 11, 26After tasting IPO success, Hemab’s CEO seeks ‘flavor of a multi-product coagulation company’
Aug 10, 26STAT+: In surprise decision, FDA rejects radiopharma therapy expected to rival Novartis treatment
Aug 10, 26STAT+: Pharmalittle: We’re reading about a Sanofi drug shortage, a Jazz Pharma deal, and more
Aug 10, 26Jazz pays $820M to buy Actio, adding clinical-stage asset to orchestra of epilepsy therapies
Aug 9, 26Taylor Fresh Foods Recalls Products Made with Jalapeno Peppers Because of Possible Health Risk